About
Basic Data Updated:
23 days agoOjas Pharmaceuticals Limited, as stated in its annual filings, is involved in the provision of pharmaceuticals and pharmacy products. The company was incorporated with the purpose of conducting various activities such as manufacturing, production, processing, conversion, refining, alteration, packing, repacking, and job work, including bottling and processing of capsules, syrups, tablets, injectables, aerosols, and ointments, as per its Memorandum of Association (MoA). These activities are carried out with the aim of meeting the growing demand for high-quality and affordable medicines in the market. The company's commitment to providing safe and effective medications has earned it a reputable position in the pharmaceutical industry. Ojas Pharmaceuticals Limited follows strict quality control measures and adheres to all regulatory guidelines to ensure that its products meet the highest standards of safety and efficacy. This dedication to quality has enabled the company to establish a loyal customer base and expand its reach to various markets globally. Moreover, Ojas Pharmaceuticals Limited is also committed to promoting research and development in the field of pharmaceuticals. The company invests heavily in cutting-edge technology and employs a team of highly skilled professionals to develop innovative and cost-effective solutions for various health conditions.
Industry
Company Details
- Location
Mahabub Nagar, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24230TG1993PLC016508 |
| Company No. | 016508 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 02 Nov 1993 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Financials of Ojas Pharmaceuticals Limited
Ojas Pharmaceuticals Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 94.71% increase in profit. The company's net worth dipped by a decrease of 0.36%.
Corporate Structure
Unlock access to Ojas Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Ojas Pharmaceuticals Limited
Unlock and access historical data on people associated with Ojas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(3)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ojas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ojas Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Degradable Polymer Technologies Private Limited
Active
13 years 7 months Shoba Jagarapu and Shabarish Jagarapu are mutual person
Recent activity within the organization
Annual General Meeting
Ojas Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Ojas Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Director Appointment
Shoba Devi Jagarapu was appointed as a Additional Director was appointed as a Additional Director on 16 Jul 2021 & has been associated with this company since 2 years 10 months .
16 Jul 2021Director Appointment
Adisesha Giri Jagarapu was appointed as a Additional Director was appointed as a Additional Director on 22 Jun 2020 & has been associated with this company since 3 years 10 months .
22 Jun 2020Director Appointment
Shabarish Jagarapu was appointed as a Additional Director was appointed as a Additional Director on 18 Jul 2008 & has been associated with this company since 15 years 10 months .
18 Jul 2008
Frequently asked questions
What is the Incorporation or founding date of Ojas Pharmaceuticals Limited?
